CDR-Life to Participate in the 2022 Jefferies London Healthcare Conference

November 1, 2022 2:10 pm Published by

Zürich, Switzerland, November 1, 2022 –CDR-Life Inc., a biotechnology company pioneering a new and differentiated class of highly tumor-selective immuno-oncology therapeutics based on its proprietary antibody-based MHC-targeting T cell engager technology, today announced that Christian Leisner, Chief Executive Officer and Björn Peters, Chief Business Officer, will participate in one-on-one meetings at the upcoming Jefferies London Healthcare Conference from November 15-17, 2022 in London, United Kingdom. 

Categorised in:

This post was written by CDR Life Editor